ENDO PHARMA LLC 4
Accession 0001209191-04-020233
Filed
Apr 11, 8:00 PM ET
Accepted
Apr 12, 12:25 PM ET
Size
48.7 KB
Accession
0001209191-04-020233
Insider Transaction Report
- Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−3,514$8,504→ 82,233,624 total - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−20,007$48,417→ 5,529,886 totalExercise: $2.42From: 2001-10-01Exp: 2007-08-26→ Common Stock (20,007 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$3.00/sh−1,699$5,097→ 82,220,120 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−10,211$24,711→ 82,290,376 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−1,126$2,725→ 82,238,219 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$3.42/sh−1,081$3,697→ 82,237,138 total - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−29,782$72,072→ 5,549,893 totalExercise: $2.42From: 2001-04-01Exp: 2007-08-26→ Common Stock (29,782 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−29,782$72,072→ 82,260,594 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−1,242$3,006→ 82,239,345 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−3,594$8,697→ 82,230,030 total - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−1,242$3,006→ 1,379,761 totalExercise: $2.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (1,242 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−3,514$8,504→ 5,526,372 totalExercise: $2.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (3,514 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−20,007$48,417→ 82,240,587 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−6,521$15,781→ 82,223,509 total - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$2.42/sh−740$1,791→ 82,219,380 total - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$3.00/sh−1,699$5,097→ 1,765,616 totalExercise: $3.00From: 2004-03-12Exp: 2007-08-26→ Common Stock (1,699 underlying) - Exercise of In-Money
Common Stock, par value $.01 per share
2004-04-09$3.00/sh−1,690$5,070→ 82,221,819 total - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$3.42/sh−1,081$3,697→ 1,251,622 totalExercise: $3.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (1,081 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−3,594$8,697→ 4,661,237 totalExercise: $2.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (3,594 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−10,211$24,711→ 5,579,675 totalExercise: $2.42From: 2001-01-01Exp: 2007-08-26→ Common Stock (10,211 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−1,126$2,725→ 1,555,651 totalExercise: $2.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (1,126 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$3.00/sh−1,690$5,070→ 3,240,006 totalExercise: $3.00From: 2004-03-12Exp: 2007-08-26→ Common Stock (1,690 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−740$1,791→ 3,038,856 totalExercise: $2.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (740 underlying) - Exercise of In-Money
Call Option (obligation to sell)
2004-04-09$2.42/sh−6,521$15,781→ 4,929,887 totalExercise: $2.42From: 2004-03-12Exp: 2007-08-26→ Common Stock (6,521 underlying)
Documents
Issuer
ENDO PHARMACEUTICALS HOLDINGS INC
CIK 0001100962
Related Parties
1- filerCIK 0001120075
Filing Metadata
- Form type
- 4
- Filed
- Apr 11, 8:00 PM ET
- Accepted
- Apr 12, 12:25 PM ET
- Size
- 48.7 KB